(NASDAQ: SGEN) Seagen's forecast annual revenue growth rate of 35.36% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.5%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.21%.
Seagen's revenue in 2023 is $1,864,113,000.On average, 9 Wall Street analysts forecast SGEN's revenue for 2023 to be $461,072,045,888, with the lowest SGEN revenue forecast at $404,211,055,967, and the highest SGEN revenue forecast at $537,332,789,984. On average, 9 Wall Street analysts forecast SGEN's revenue for 2024 to be $620,681,848,671, with the lowest SGEN revenue forecast at $502,409,222,106, and the highest SGEN revenue forecast at $806,064,167,692.
In 2025, SGEN is forecast to generate $881,860,563,870 in revenue, with the lowest revenue forecast at $716,802,053,238 and the highest revenue forecast at $1,167,200,966,627.